Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149143789> ?p ?o ?g. }
- W2149143789 endingPage "764" @default.
- W2149143789 startingPage "756" @default.
- W2149143789 abstract "Background: We and others have previously shown that plasminogen activators generate endogenous angiogenesis inhibitors and induce antiangiogenic activity. Here we assessed the effects of plasminogen activator overexpression on tumor progression in a syngeneic mammary cancer model. Methods: Genes encoding murine tissue plasminogen activator (tPA), urokinase (uPA), and vector controls were stably transfected into 4T1 murine mammary cancer cells, and cell proliferation in vitro was analyzed. Cells were also implanted into female BALB/c mice (n = 12 per group), and tumor growth, lung metastases, and survival were compared. Tumor cell proliferation and microvessel formation were analyzed by immunohistochemistry using antibodies to proliferating cell nuclear antigen and CD31, respectively. 4T1 cells transfected with proteolytically inactive uPA mutants (A and B) were assayed for proliferation in vitro and tumor growth in vivo by using the same syngeneic model (eight to 10 mice per group). All statistical tests were two-sided. Results: In vitro growth of uPA- and tPA-overexpressing and control 4T1 cells was similar. In vivo, however, inhibition of tumor growth and lung metastasis were inhibited in the mice carrying tPA- and uPA-overexpressing tumors, compared with controls (tumor weight at day 34: control, mean = 1760 mg, 95% confidence interval [CI] = 1434 to 2087 mg; tPA, mean = 921, 95% CI = 624 to 1217 mg; P <.001; uPA, mean = 395 mg, 95% CI = 161 to 629 mg; P <.001; number of lung metastases at day 34: control, mean = 117, 95% CI = 74 to 159; tPA, mean = 33, 95% CI = 13 to 52; uPA, mean = 15, 95% CI = 4 to 25; P <.001). Median survival was 42 (95% CI = 36 to 44), 55 (95% CI = 48 to 61), and 73 (95% CI = 51 to 86) days in the control, tPA, and uPA groups, respectively ( P <.001). uPA- and tPA-expressing tumors had reduced angiogenesis and cell proliferation compared with controls. Tumors overexpressing uPA mutants grew faster than tumors expressing wild-type uPA (tumor volume at day 30: wild-type uPA, mean = 203, 95% CI = 121 to 285 mm 3 ; control, mean = 534, 95% CI = 460 to 608 mm 3 ; P <.001; mutant A, mean = 600, 95% CI = 520 to 679 mm 3 ; P <.001; and mutant B, mean = 435, 95% CI = 358.9 to 511 mm 3 ; P = .005). Conclusions: In this mouse model, uPA expression delayed tumor progression and had antiangiogenic and antiproliferative effects that may be mediated by uPA's protease activity. These results challenge the current dogma of proteases being exclusively tumor promoting and provide further rationale for exploring plasminogen activators as antitumor agents." @default.
- W2149143789 created "2016-06-24" @default.
- W2149143789 creator A5008499020 @default.
- W2149143789 creator A5016609472 @default.
- W2149143789 creator A5022619172 @default.
- W2149143789 creator A5046981381 @default.
- W2149143789 creator A5051470930 @default.
- W2149143789 creator A5061137912 @default.
- W2149143789 creator A5075475504 @default.
- W2149143789 creator A5079758770 @default.
- W2149143789 creator A5083885611 @default.
- W2149143789 date "2006-06-07" @default.
- W2149143789 modified "2023-09-24" @default.
- W2149143789 title "Protease Activity of Urokinase and Tumor Progression in a Syngeneic Mammary Cancer Model" @default.
- W2149143789 cites W1574172480 @default.
- W2149143789 cites W1593681564 @default.
- W2149143789 cites W1638772292 @default.
- W2149143789 cites W1796791327 @default.
- W2149143789 cites W1954229725 @default.
- W2149143789 cites W1967940704 @default.
- W2149143789 cites W1968673560 @default.
- W2149143789 cites W1981765089 @default.
- W2149143789 cites W1993667909 @default.
- W2149143789 cites W2005113904 @default.
- W2149143789 cites W2013336992 @default.
- W2149143789 cites W2017849543 @default.
- W2149143789 cites W2023284036 @default.
- W2149143789 cites W2032220711 @default.
- W2149143789 cites W2036537191 @default.
- W2149143789 cites W2038764988 @default.
- W2149143789 cites W2046179006 @default.
- W2149143789 cites W2053539393 @default.
- W2149143789 cites W2058903925 @default.
- W2149143789 cites W2063210598 @default.
- W2149143789 cites W2063482106 @default.
- W2149143789 cites W2067055348 @default.
- W2149143789 cites W2090722568 @default.
- W2149143789 cites W2092839736 @default.
- W2149143789 cites W2095922581 @default.
- W2149143789 cites W2106717388 @default.
- W2149143789 cites W2106858635 @default.
- W2149143789 cites W2137400219 @default.
- W2149143789 cites W2150552267 @default.
- W2149143789 cites W2150776809 @default.
- W2149143789 cites W2152728784 @default.
- W2149143789 cites W2155295822 @default.
- W2149143789 cites W2165132221 @default.
- W2149143789 cites W2167413291 @default.
- W2149143789 cites W2177527791 @default.
- W2149143789 cites W2177606629 @default.
- W2149143789 cites W2330364671 @default.
- W2149143789 cites W2396086641 @default.
- W2149143789 cites W4231451806 @default.
- W2149143789 cites W4232804398 @default.
- W2149143789 doi "https://doi.org/10.1093/jnci/djj208" @default.
- W2149143789 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16757700" @default.
- W2149143789 hasPublicationYear "2006" @default.
- W2149143789 type Work @default.
- W2149143789 sameAs 2149143789 @default.
- W2149143789 citedByCount "11" @default.
- W2149143789 countsByYear W21491437892012 @default.
- W2149143789 countsByYear W21491437892014 @default.
- W2149143789 countsByYear W21491437892020 @default.
- W2149143789 crossrefType "journal-article" @default.
- W2149143789 hasAuthorship W2149143789A5008499020 @default.
- W2149143789 hasAuthorship W2149143789A5016609472 @default.
- W2149143789 hasAuthorship W2149143789A5022619172 @default.
- W2149143789 hasAuthorship W2149143789A5046981381 @default.
- W2149143789 hasAuthorship W2149143789A5051470930 @default.
- W2149143789 hasAuthorship W2149143789A5061137912 @default.
- W2149143789 hasAuthorship W2149143789A5075475504 @default.
- W2149143789 hasAuthorship W2149143789A5079758770 @default.
- W2149143789 hasAuthorship W2149143789A5083885611 @default.
- W2149143789 hasBestOaLocation W21491437892 @default.
- W2149143789 hasConcept C121608353 @default.
- W2149143789 hasConcept C126322002 @default.
- W2149143789 hasConcept C134018914 @default.
- W2149143789 hasConcept C142724271 @default.
- W2149143789 hasConcept C150903083 @default.
- W2149143789 hasConcept C207001950 @default.
- W2149143789 hasConcept C2776187077 @default.
- W2149143789 hasConcept C2776256026 @default.
- W2149143789 hasConcept C2776892390 @default.
- W2149143789 hasConcept C2779013556 @default.
- W2149143789 hasConcept C2779256057 @default.
- W2149143789 hasConcept C2779679481 @default.
- W2149143789 hasConcept C2780394083 @default.
- W2149143789 hasConcept C502942594 @default.
- W2149143789 hasConcept C530470458 @default.
- W2149143789 hasConcept C54009773 @default.
- W2149143789 hasConcept C54355233 @default.
- W2149143789 hasConcept C62112901 @default.
- W2149143789 hasConcept C71924100 @default.
- W2149143789 hasConcept C81885089 @default.
- W2149143789 hasConcept C86803240 @default.
- W2149143789 hasConceptScore W2149143789C121608353 @default.
- W2149143789 hasConceptScore W2149143789C126322002 @default.
- W2149143789 hasConceptScore W2149143789C134018914 @default.